Alexion Pharmaceuticals Earnings Preview For Tuesday (ALXN)
Alexion Pharmaceuticals (NASDAQ:ALXN) will be releasing last fiscal quarter's results before the opening bell on April 24, 2012. We can review how Alexion Pharmaceuticals has executed for investors recently.
Who They Are: . The company was founded in 1992 and is headquartered in Cheshire, Connecticut. Alexion Pharmaceuticals trades an average of 1.3 million shares per day and has a marketcap of $16.7 Billion.
Book Value: $6.12
Float Short: 1.65%
What To Expect:
On average, 8 Analysts are expecting a drop of $-0.02 in earnings per share compared to last quarter's results of $0.41. Investors will be looking to top $0.39 per share based on the estimated mean earnings.
Recent Stock and Valuation Performance:
The P/E ratio has trended lower, as the current trailing twelve months P/E ratio is 77, while the forward P/E ratio is now 60.97.
In the last month, the stock has decreased in price -0.34%, and 83.04% from one year ago.
With a double digit gain compared to stocks in general, the stock shares did very well as compared to the overall stock market. When comparing to the S&P 500, the year up to date change is 13.46%.
Here are the last few quarters to get an idea how well they perform compared to estimates
Reported earnings per share compared to the mean estimate. Differences are rounded.
Paid2Trade uses information believed to be correct, but is not guaranteed and is not independently checked for accuracy You may wish to use this article as a starting point of your own research with your financial planner.